Interestingly, POSTN levels before and after chemotherapy correlated significantly with prognosis suggesting that POSTN levels could be able to predict chemotherapy response and survival in patients with advanced NSCLC (90). This evidence concerns the gene POSTN and non-small cell lung carcinoma.